Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of the International AIDS Society|November 15, 2014
Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNAClaudia Bianco, Genny Meini, Barbara Rossetti, et al.The Journal of Antimicrobial Chemotherapy|January 20, 2012
Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in ItalyIlaria Vicenti, Andrea Rosi, Francesco Saladini, et al.Retrovirology|July 2, 2010
Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotypingMattia C F Prosperi, Laura Bracciale, Massimiliano Fabbiani, et al.The Journal of Antimicrobial Chemotherapy|October 25, 2013
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapyGenny Meini, Barbara Rossetti, Claudia Bianco, et al.Journal of Medical Virology|October 29, 2010
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practiceMattia C F Prosperi, Maurizio Zazzi, Grazia Punzi, et al.HIV Clinical Trials|February 13, 2014
Genotypic determination of HIV tropism in a cohort of patients perinatally infected with HIV-1 and exposed to antiretroviral therapyAntonio Di Biagio, Andrea Parisini, Bianca Bruzzone, et al.BMC Medical Informatics and Decision Making|June 16, 2011
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimenMattia C F Prosperi, Simona Di Giambenedetto, Iuri Fanti, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 7, 2016
First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testingGenny Meini, Cinzia Dello Russo, Tiziano Allice, et al.Plos One|November 22, 2017
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trialBarbara Rossetti, Roberta Gagliardini, Genny Meini, et al.The New Microbiologica|October 20, 2010
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study GroupValentina Svicher, Roberta D'Arrigo, Claudia Alteri, et al.Pageof 3